To assess the developmental trends of thyroid nodules over an extended follow-up period and evaluate the diagnostic efficacy of C-TIRADS compared to Kwak TI-RADS, highlighting the importance of these assessments in clinical practice.
Key Findings:
The AUC for C-TIRADS was 0.784, with a category of ≥4B yielding sensitivity of 75.72% and specificity of 75.76%.
No statistically significant difference was found in diagnostic efficacy between C-TIRADS and Kwak TI-RADS.
Microcalcifications, irregular margins, and internal vascularity were increasingly observed in nodules over time.
Interpretation:
C-TIRADS demonstrates diagnostic accuracy comparable to Kwak TI-RADS, reinforcing its clinical utility in thyroid nodule management.
Limitations:
Study conducted at a single center, which may limit generalizability and applicability to broader populations.
Exclusion of indeterminate cases may affect the overall findings and limit the understanding of diagnostic performance.
Conclusion:
C-TIRADS is clinically useful for thyroid nodule management, showing similar diagnostic performance to Kwak TI-RADS.
